{
    "2018-05-21": [
        [
            {
                "time": "2018-05-14",
                "original_text": "It’s Not as Bad as It Looks for Johnson & Johnson Stock",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "Not as Bad"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "How to Play the Long Side of Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Long Side",
                        "Play"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-16",
                "original_text": "Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest",
                "features": {
                    "keywords": [
                        "FDA",
                        "Shaming",
                        "Drug Companies",
                        "Financial Advisors"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-17",
                "original_text": "7 ‘Blue-Chip Stocks’ That Aren’t Blue Chips at All",
                "features": {
                    "keywords": [
                        "Blue-Chip Stocks",
                        "Aren’t Blue Chips"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-18",
                "original_text": "3 Days Left To Cash In On Johnson & Johnson (NYSE:JNJ) Dividend, Is It Worth Buying?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Dividend",
                        "Worth Buying"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-19",
                "original_text": "Today's Research Reports on Trending Tickers: Johnson & Johnson and The Procter & Gamble",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Trending Tickers",
                        "Johnson & Johnson",
                        "Procter & Gamble"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "The Week Ahead In Biotech: PDUFA Dates, IPOs And More",
                "features": {
                    "keywords": [
                        "Week Ahead",
                        "Biotech",
                        "PDUFA Dates",
                        "IPOs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-21",
                "original_text": "A Look into Roche Holding’s Performance in Q1 2018",
                "features": {
                    "keywords": [
                        "Roche Holding",
                        "Performance",
                        "Q1 2018"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}